Ipamorelin and CJC-1295 without DAC (Mod GRF 1-29) are synthetic research peptides that are used together in experimental models to investigate the regulation of the growth hormone axis and mechanisms of somatotropic signaling.
Browse nearby entries from the full catalog, starting with Peptide Supplier.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantIpamorelin and CJC-1295 without DAC (Mod GRF 1-29) are synthetic research peptides that are used together in experimental models to investigate the regulation of the growth hormone axis and mechanisms of somatotropic signaling. Ipamorelin is a selective pentapeptide growth hormone secretagogue that acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a), activating the Gq/PLC- and calcium-dependent intracellular signaling pathways involved in GH release, while it shows only minimal interactions with other pituitary hormones in preclinical systems. CJC-1295 without DAC is a stabilized analogue of the growth hormone-releasing hormone (GHRH 1-29), which selectively activates the GHRH receptor, stimulates adenylate cyclase and the cAMP-mediated signaling pathway in pituitary somotropes. Preclinical research uses the combined activation of GHS-R1a- and GHRH receptors to study synergistic GH secretion, hypothalamic–pituitary feedback mechanisms, and the pharmacology of endocrine receptors in controlled laboratory conditions.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.